Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACCW)

CUSIP: G6717R112

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Class A ordinary shares, par value $0.0001 per share
Total 13F shares
2,851,427
Total 13F value
$2,088,196
Holder snapshot 6 signals
Share change
-49,558
SEC-reported price per share
$0.71
Number of holders
30
Value change
-$35,774
Number of buys
2
Number of sells
8
Security identity Who this page is about. 1 source field
Shares outstanding
19,607,843

Security key

G6717R112

Report period

Q4 2025

Institutions

30

Top holders

10

OACCW full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Oaktree Acquisition Corp. III Life Sciences SEC filings Oaktree Acquisition Corp. III Life Sciences company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OACCW - Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Oaktree Acquisition Holdi...
Disclosed value leader
Oaktree Acquisition Holdi...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 3/4/5 13F Lead comparable stake: 22% 13D/G row: Oaktree Acquisition Holdings III LS, LLC Showing 1-6 of 15 holder rows.

Quick read

Oaktree Acquisition Holdings III LS, LLC leads the comparable SEC ownership view at 22%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
Oaktree Acquisition Holdings III ... 22%
AQR CAPITAL MANAGEMENT LLC 7.3%
BARCLAYS PLC 4.4%
GOLDMAN SACHS GROUP INC 4.1%
HEALTHCARE OF ONTARIO PENSION PLA... 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Oaktree Acquisition Holdings III LS, LLC
13D/G 3/4/5
10%+ Owner
13D/G 3/4/5
22%
$56,160,462
5,500,535 shares
 $0 31 Dec 2024
AQR CAPITAL MANAGEMENT LLC
13D/G
13D/G
7.3%
$14,812,158
1,450,750 shares
 $0 31 Mar 2025
BARCLAYS PLC
13D/G
13D/G
4.4%
$9,115,992
861,625 shares
 -$4,628,750 31 Dec 2025
GOLDMAN SACHS GROUP INC
13D/G 13F
THE GOLDMAN SACHS GROUP, INC. · Company
13D/G 13F
4.1%
$8,396,439
803,487 shares
 -$5,580,457 30 Jun 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13D/G 13F
Company
13D/G 13F
3.5%
$7,147,000
700,000 shares
 -$10,210,000 31 Mar 2025
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
13D/G 13F
1.4%
$2,915,734
277,689 shares
 $0 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
30
Shares
2,851,427
Rows available
30
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
28
Q4 2025 holders
30
Holder diff
2
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .